Skip to main content
Premium Trial:

Request an Annual Quote

Cengent Therapeutics and University of Alabama to Offer Joint Structure Determination Service

NEW YORK, Feb. 23 (GenomeWeb News) - Cengent Therapeutics and the Center for Biophysical Sciences and Engineering at the University of Alabama at Birmingham will jointly offer a target/drug-lead structure determination service, Cengent said today.


CBSE's existing high-throughput X-ray crystallography service for industry will be complemented by Cengent's computational Gene to Leads technology.


In addition, Cengent will make use of CBSE's crystallography capabilities for its internal drug discovery program.


Cengent Therapeutics emerged from the fusion of Structural Bioinformatics and GeneFormatics last year.


The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.